血清素受體對於發育中初級神經細胞
NMDA 受體表現之影響
The Effect of Serotonin Receptor on the Developmental
Expression of NMDA Receptor on the Primary Cortical
Neuronal Cultures
中文摘要
血清素 (serotonin, 5-HT) 及其受體在神經細胞的許多發育分化過程中扮演
很重要的角色。先前的研究曾發現血清素在細胞培養中能促進大腦皮質神經細胞
的存活。相較之下麩氨酸受體 (Glutamate receptor) 的亞型
N-methyl-D-aspartate (NMDA) 受體在胚胎大腦皮質中表現的時間較晚。因
此，
NMDA 受體的表現有可能會受到血清素及其受體活性之影響。本實驗探討：
長期暴露於血清素受體拮抗劑，對大白鼠初級大腦皮質神經細胞中
NMDA 受體
的表現及活性之影響。結果顯示大白鼠初級皮質神經細胞之
NR1、NR2A、NR2B
等
NMDA 受體次單元的表現，隨著培養天數而逐漸增加，於第 10 至 20 天達到
高峰。長時期 (10 個培養天) 暴露於高濃度的 methysergide maleate (100
μM) 或 dihydroergocristine mesylate (10μM) 兩種 5-HT1 及 5-HT2 的
非特異性拮抗劑會導致明顯的細胞毒性。低濃度
methysergide maleate
(1~10μM) 或 dihydroergocristine mesylate (1μM) 則不會產生細胞毒
性。長期培養於
dihydroergocristine mesylate ( 1μM) 會降低 NMDA 受體
次單元
NR1 及 NR2A 的表現量。而細胞長期培養於 methysergide maleate
(1~10μM)、 dihydroergocristine mesylate (1μM)、5-HT1a 拮抗劑
pindolol (1μM) 或 5-HT2A 拮抗劑 cyproheptadine hydrochloride (1μ
M) 會顯著降低細胞對 NMDA 引發的細胞毒性的敏感度。此結果顯示早期阻斷
血清素受體活性可明顯抑制
NMDA 受體的表現，且此種抑制作用可能包含受體
量與質的變化。
英文摘要
Serotonin (5-HT) is known to regulate many developmental processes of
serotonergic neurons and their target area through its many receptors with distinct characters and functions. In developing rat brain, the axons of serotonergic neuron reach the cortex around embryonic day 16, when neurogenesis is taking place. Previously, it has been shown that serotonin can promote the survival of cortical glutamatergic neurons in culture. Since the expression of NMDA receptor in cortex is after the development of serotonergic neurons, it is possible that the expression of NMDA receptor is under the influence of the activity of 5-HT and its receptors. To test this hypothesis, we used the rat primary cortical cell culture to determine whether long-term exposure of non-selective antagonists of 5-HT1/2 receptor, the
methysergide maleate and dihydroergocristine mesylate, affected the expression of the NMDA receptor subunit protein, namely NR1, NR2A and NR2B, and whether the alteration of the receptor affected the sensitivity of cultured cell to the
NMDA-induced neurotoxicity. Immunoblotting assay showed that the expressions of NR1, NR2A, and NR2B increased as increase in the day in vitro (DIV), and reached the plateau around DIV10 to 20. 10-day incubation with high concentration of the methysergide maleate (100μM) or dihydroergocristine mesylate (10μM) is cytotoxic to the cortical cell culture. However, low concentration of methysergide maleate (1μM or 10μM) or dihydroergocristine mesylate (1μM) did not produce cell toxicity. Long-term exposure to dihydroergocristine mesylate (1μM) significantly decreases the expression of NR1 and NR2A subunits. LDH assay showed that long-term exposure to methysergide maleate (10μM), dihydroergocristine mesylate (1μM), and pindolol (1μM), a selective antagonist of 5-HT1A and cyproheptadine
hydrochloride (1μM), a selective antagonist of 5-HT2A, reduced the sensitivity of cell to NMDA-induced cell toxicity. This result showed that long-term decreasing the activity of serotonin receptor could decrease the expression of NMDA receptor in both quantitative and qualitative manner in developing cortical neuronal cultured cell.
